Optimizing Drug Therapy Through Pharmacokinetics and Therapeutic Drug Monitoring
A Special Issue of Pharmaceutics (ISSN 1999-4923) belonging to the section "Pharmacokinetics and Pharmacodynamics".
Deadline for manuscript submissions: 30 September 2026 | Viewed by 423
Editors
Interests: population pharmacokinetics; pharmacodynamics; therapeutic drug monitoring; modeling & simulation
Interests: special population; population pharmacokinetic modeling; physiologically based pharmacokintic modeling; tissue penetration; pharmacodynamics; prediction of efficacy and toxicity; therapeutic drug monitoring
Special Issue Information
Dear Colleagues,
It is common knowledge that advances in individualized therapy have greatly contributed to improving drug treatment outcomes. Research on optimizing therapy through pharmacokinetic changes and therapeutic drug monitoring based on basic patient information, biomarkers and genetics has made remarkable progress and is expected to contribute greatly to future medical advances. In particular, high-quality evidence is desirable for special populations (e.g., pediatrics, pregnancy, obese, and dialysis), for which patient numbers are small and sampling is difficult. In recent years, there has been an increasing number of reports on optimizing therapy using mathematical models such as population pharmacokinetic models and physiologically based pharmacokinetic models, as well as utilizing artificial intelligence.
This Special Issue provides insights into individually optimized treatment based on pharmacokinetics and TDM, regardless of the field, including various domains such as anticancer, antimicrobial, cardiovascular, immunosuppressive and psychiatric drugs.
Dr. Kazuro Ikawa
Dr. Tetsushu Onita
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- dosing optimization
- therapeutic drug monitoring
- pharmacokinetics
- pharmacodynamics
- modeling and simulation
- special population
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
